The tolerability of clopidogrel napadisilate was comparable with that of clopidogrel bisulfate in terms of all AEs , drug-related AEs , and serious AEs ( all AEs : test group , 33.3 % ; control group , 32.9 % [ P > 0.99 ] ; drug-related AEs : test group , 4.17 % ; control group , 0 % [ P = 0.113 ] ; serious AEs : test group , 1.39 % ; control group , 5.26 % [ P = 0.367 ] ) .
